Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-20 Sale | 2024-09-24 8:24 pm | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 42,068 | $29.03 | $1,221,133 | 118,070 (Direct) | View |
2024-05-02 Sale | 2024-05-03 6:29 pm | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 1,718 | $18.91 | $32,487 | 18,631 (Direct) | View |
2024-02-07 Sale | 2024-02-09 5:42 pm | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 10,000 | $20.03 | $200,258 | 456,271 (Direct) | View |
2023-05-02 Sale | 2023-05-03 6:26 pm | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 1,747 | $8.9049 | $15,557 | 17,437 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-20 Exercise | 2024-09-24 8:24 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 42,068 | $1.93 | 118,070 (Direct) | View |
2024-09-20 Exercise | 2024-09-24 8:24 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 42,068 | $0 | 118,070 (Direct) | View |
2024-08-12 Option Award | 2024-08-14 4:14 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 161,875 | $0 | 161,875 (Direct) | View |
2024-05-01 Exercise | 2024-05-03 6:29 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 5,208 | $0 | 18,631 (Direct) | View |
2024-02-07 Exercise | 2024-02-09 5:42 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 10,000 | $1.93 | 456,271 (Direct) | View |
2024-02-07 Exercise | 2024-02-09 5:42 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 10,000 | $0 | 456,271 (Direct) | View |
2023-08-17 Option Award | 2023-08-18 7:13 pm | N/A 2033-08-17 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 220,000 | $0 | 220,000 (Direct) | View |
2023-05-01 Exercise | 2023-05-03 6:26 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 5,208 | $0 | 17,437 (Direct) | View |
2022-08-08 Option Award | 2022-08-10 5:42 pm | N/A 2032-08-08 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 200,000 | $0 | 200,000 (Direct) | View |
2022-05-01 Option Award | 2022-05-03 4:14 pm | N/A 2025-05-01 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 15,625 | $0 | 15,625 (Direct) | View |
2021-08-17 Option Award | 2021-08-19 5:09 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 140,000 | $0 | 140,000 (Direct) | View |
Ownership | 2021-03-25 9:35 pm | N/A 2030-09-21 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 0 | $0 | 443,180 (Direct) | View |